Donnie Rudd
Plus aucun poste en cours
Profil
Dr. Donnie Rudd is Chief Scientific Officer at Regenetech, Inc. and Chief Scientist & Director-Intellectual Property at Endonovo Therapeutics, Inc.
He received his undergraduate degree from Texas A&M University and a graduate degree from the Chicago-Kent College of Law.
Anciens postes connus de Donnie Rudd
| Sociétés | Poste | Fin |
|---|---|---|
| ENDONOVO THERAPEUTICS, INC. | Directeur Technique/Scientifique/R&D | - |
Regenetech, Inc.
 Regenetech, Inc. Miscellaneous Commercial ServicesCommercial Services Regenetech, Inc. develops and distributes tissue regeneration technology. It provides research and development services for adult stem cells expansion and therapeutic applications. The firm offers umbilical cord and peripheral blood expansion, bone regeneration, and biomolecules producing therapeutic technologies. The company was founded in April, 2002 and is headquartered in Houston, TX. | Directeur Technique/Scientifique/R&D | - |
Formation de Donnie Rudd
| Texas A&M University | Undergraduate Degree |
| Chicago-Kent College of Law | Graduate Degree |
Expériences
Fonctions occupées
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| ENDONOVO THERAPEUTICS, INC. | Health Technology |
| Entreprise privées | 1 |
|---|---|
Regenetech, Inc.
Regenetech, Inc. Miscellaneous Commercial ServicesCommercial Services Regenetech, Inc. develops and distributes tissue regeneration technology. It provides research and development services for adult stem cells expansion and therapeutic applications. The firm offers umbilical cord and peripheral blood expansion, bone regeneration, and biomolecules producing therapeutic technologies. The company was founded in April, 2002 and is headquartered in Houston, TX. | Commercial Services |
